Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 7/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | PREP | P48147 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30139041 | 0.97 | ACE (0.45) | ACELMNASMN1; SMN2OPRD1PREP | |
| SCHEMBL30139006 | 0.97 | ACE (0.45) | ACELMNASMN1; SMN2OPRD1PREP | |
| SCHEMBL29759519 | 0.91 | ACE (0.52) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL21467260 | 0.91 | ACE (0.52) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL31217850 | 0.91 | ACE (0.52) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL17015151 | 0.91 | ACE (0.52) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL8611807 | 0.87 | ACE (0.49) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL8611810 | 0.87 | ACE (0.49) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL29696690 | 0.87 | ACE (0.49) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL30139010 | 0.87 | ACE (0.49) | ACELMNASMN1; SMN2PREPACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115181173-A | Preparation method of Tirzepatide | 深圳市健元医药科技有限公司 | 2022-10-14 | — | — | CN | disclosed |